- Report
- October 2025
- 160 Pages
Global
From €2997EUR$3,358USD£2,597GBP
€3526EUR$3,950USD£3,055GBP
- Report
- October 2025
- 160 Pages
Global
From €2997EUR$3,358USD£2,597GBP
€3526EUR$3,950USD£3,055GBP
- Report
- August 2025
- 150 Pages
Global
From €2921EUR$3,273USD£2,531GBP
€3436EUR$3,850USD£2,978GBP
- Report
- September 2025
- 72 Pages
Global
From €3500EUR$4,201USD£3,139GBP
- Report
- July 2025
- 112 Pages
Global
From €3500EUR$4,201USD£3,139GBP
- Report
- July 2025
- 85 Pages
Global
From €3500EUR$4,201USD£3,139GBP
- Report
- July 2025
- 226 Pages
Global
From €3972EUR$4,450USD£3,442GBP
- Report
- June 2025
- 300 Pages
Latin America
From €3453EUR$3,869USD£2,992GBP
- Report
- July 2020
- 269 Pages
Global
From €3121EUR$3,497USD£2,705GBP
- Report
- October 2023
- 192 Pages
Global
From €4718EUR$5,471USD£3,950GBP
- Report
- April 2025
- 387 Pages
Global
From €4016EUR$4,500USD£3,480GBP
- Report
- January 2024
- 213 Pages
Global
From €4150EUR$4,650USD£3,596GBP
- Report
- September 2022
- 110 Pages
Global
From €4909EUR$5,500USD£4,254GBP
- Report
- September 2025
- 150 Pages
India
From €3526EUR$3,950USD£3,055GBP
- Report
- May 2025
- 200 Pages
Global
From €2222EUR$2,490USD£1,926GBP
- Report
- August 2023
- 370 Pages
Global
From €2222EUR$2,490USD£1,926GBP
- Report
- July 2023
- 210 Pages
Global
From €1776EUR$1,990USD£1,539GBP
- Report
- January 2023
- 170 Pages
China
From €2222EUR$2,490USD£1,926GBP
- Report
- January 2024
- 200 Pages
Global
From €3704EUR$4,150USD£3,210GBP
- Report
- January 2024
- 200 Pages
Global
From €3704EUR$4,150USD£3,210GBP

The Flu Vaccine market is a subset of the larger Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Flu Vaccines are specifically designed to protect against influenza, a highly contagious virus that can cause severe illness and even death. Flu Vaccines are typically administered annually, and are recommended for people of all ages, including pregnant women and those with chronic health conditions.
Flu Vaccines are typically developed by pharmaceutical companies, and are then approved and distributed by government health agencies. In addition to traditional flu vaccines, there are also recombinant vaccines, which are produced using genetic engineering techniques.
Companies in the Flu Vaccine market include Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Pfizer, and Novartis. Show Less Read more